As of December 15, 2025, BIOLASE Inc (BIOL) reports a Current Ratio of 1.26.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of BIOLASE Inc's Current Ratio
Over recent years, BIOLASE Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2023-12-31 | 1.26 |
| 2022-12-31 | 1.63 |
| 2021-12-31 | 3.57 |
| 2020-12-31 | 3.13 |
| 2019-12-31 | 1.05 |
This slight downward trend highlights how BIOLASE Inc manages its short-term assets and liabilities over time.
Comparing BIOLASE Inc's Current Ratio to Peers
To better understand BIOLASE Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| BIOLASE Inc (BIOL) | 1.26 |
| Rewalk Robotics Ltd (RWLK) | 15.17 |
| Delcath Systems Inc (DCTH) | 12.01 |
| Sensus Healthcare Inc (SRTS) | 9.64 |
| IRadimed Corp (IRMD) | 8.84 |
| Conformis Inc (CFMS) | 5.63 |
Compared to its competitors, BIOLASE Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.